Novavax Covid Jab Highly Effective, But Not Against South Africa Variant Posted By: Unknown 16:57 Leave a Reply US biotech firm Novavax said Thursday its two-shot Covid-19 vaccine showed an overall efficacy of 89.3 percent in a major Phase 3 clinical trial in Britain, and remained highly effective against a... from NDTV News - Latest https://ift.tt/36lyTbO Tweet Share Share Share Share
0 comments: